RxDoctor Payments Data

Ashley Hisel, DO

Family Medicine · Topeka, KSNPI 1134431497

Payments from drug & device makers

$760in general payments, 2019–2025

Across 59 payments — averaging $12.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$145
  • Sunovion Pharmaceuticals Inc.$63
  • GSK$48
  • Supernus Pharmaceuticals, Inc.$46
  • Johnson & Johnson$42
  • AstraZeneca$38
  • plus $379 from 18 others

What the payments were for

  • Food & beverage$760100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$760 in reported general payments places this provider in the 55th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$94,874
Medicare patients
262
Services billed
1,374

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide39$67,628
JardianceEmpagliflozin15$21,069
TrulicityDulaglutide13$18,750
MounjaroTirzepatide12$14,302
EliquisApixaban21$12,513
XareltoRivaroxaban15$11,504
MyrbetriqMirabegron13$6,226
Bevespi AerosphereGlycopyrrolate/Formoterol Fum13$5,820
Spiriva RespimatTiotropium Bromide11$5,706
Xtampza ErOxycodone Myristate11$5,559
Advair HfaFluticasone Propion/Salmeterol12$5,058
Buprenorphine12$4,340
DuleraMometasone/Formoterol12$4,043
Morphine Sulfate ErMorphine Sulfate14$2,884
Atorvastatin Calcium286$2,689

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$26$67,62839 claims
Lilly USA, LLCTrulicity, Mounjaro$11$33,05225 claims
Boehringer IngelheimJardiance, Spiriva Respimat$145$26,77526 claims
PfizerEliquis$29$12,51321 claims
Johnson & JohnsonXarelto$42$11,50415 claims
AstraZenecaBevespi Aerosphere$38$5,82013 claims
MerckDulera$25$4,04312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Topeka

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →